Results 271 to 280 of about 1,419,402 (298)

The US Orphan Drug Programme 1983-1995

Pharmacoeconomics, 2012
Michael Manocchia
exaly  

Progress on Orphan Drugs

American Pharmacy, 1987
openaire   +2 more sources

Worldwide collaboration for orphan drug designation

Nature Reviews Drug Discovery, 2016
Bruno Sepodes, Segundo Mariz, Mariz Segundo   +2 more
exaly  

Orphan drugs and orphan drug legislation

2013
openaire   +1 more source

A comparative study of European rare disease and orphan drug markets

Health Policy, 2010
Lut Mergaert, Steven Simoens, Irina Cleemput   +2 more
exaly  

Review of regulatory recommendations for orphan drug submissions in the netherlands and scotland: focus on the underlying pharmacoeconomic evaluations

Clinical Therapeutics, 2010
Stefan Vegter, Mark H Rozenbaum
exaly  

Orphan diseases and orphan drugs

Food and Chemical Toxicology, 1987
openaire   +1 more source

Orphan Drugs

2009
Meijer, I., Vos, R., de Jong-van den Berg, L.T.W., Meijer, D.K.F.   +3 more
openaire   +3 more sources

When Everyone Is an Orphan: Against Adopting a U.S.-Styled Orphan Drug Policy in Canada

Accountability in Research, 2013
Matthew Herder
exaly  

Orphan diseases and Orphan drugs

Journal of Pharmaceutical Sciences, 1988
openaire   +1 more source